Shearwood McClelland III

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Shearwood McClelland III

Oct 11, 2024, 15:13 | Blog

Shearwood McClelland III: Grateful to Radiation Oncology Institute for recognizing our Navigator-Assisted Hypofractionation program

Shearwood McClelland III shared a post on X: ''Once again grateful to the Radiation Oncology…

Sep 30, 2024, 15:52 | Societies

ASTRO24: 20 Posts Not To Miss From Day 1

The 66th Annual Meeting of the American Society for Radiation Oncology (ASTRO) is ongoing at…

Sep 28, 2024, 16:13 | Societies

18 Posts Not To Miss From ASCOQLTY24 Day 1

The 2024 ASCO Quality Care Symposium is currently taking place on September 27-28, 2024, in…

Aug 16, 2024, 19:37 | Insight

Shearwood McClelland III: Financial Toxicity associated with achieving PFS based on the INDIGO trial

Shearwood McClelland III, Director of Spine Oncology, Department of Radiation Oncology at University Hospitals, shared…

Aug 5, 2024, 11:15 | Dialogues

ASCO24 Updates: Is There a Prognosis Gap in Spine Metastasis Treatment?

The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…

Jun 21, 2024, 11:13 | Blog

2024 ASTRO-BCRF Trainee Travel Award

Shearwood McClelland III, Director of Spine Oncology, Department of Radiation Oncology at University Hospitals, shared a…

Jun 15, 2024, 05:10 | Blog

Shearwood McClelland III: Grateful to have won an Radiation Oncology Institute Grant

Shearwood McClelland III, Director of Spine Oncology, Department of Radiation Oncology at University Hospitals, made…

All: 7 Posts: 1 - 100

'

April is Head and Neck Cancer Awareness Month

'

Is Cancer Hereditary? Myths and Facts about Cancer Genetics

'

Neuroendocrine Lung Tumors: Types, Symptoms, Diagnosis, Treatment and 2025 updates

'

Cancer Center Near Me: Dana-Farber Cancer Institute

'

FDA Approves Nivolumab and Ipilimumab for First-Line Treatment of Unresectable Hepatocellular Carcinoma Based on CheckMate-9DW Trial

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023